This week its about something Ive been wrestling with for over a year - peptides (read Ozempic, BPC-157)
Panels focus on substances with demonstrated workplace impairment or safety risk
Theoretically, BPC-157 shows faster onset (4-6 days in animal models vs 2-6 weeks for human SSRIs), multi-system modulation rather than single-target effects, actual neuronal repair and regeneration (neuroprotection), no withdrawal syndrome in animals, and efficacy when given peripherally without extensive blood-brain barrier crossing
A phase 2 clinical trial published in The New England Journal of Medicine enrolled 338 patients with a body-mass index of 30 or higher or those with a BMI of 27 to less than 30 with at least one weight-related condition
It helps in the maintenance of a healthy liver and kidneys
Cancer 75 , 589592 (1997)